Medwin Publishers

Discover Research Beta

Browse peer-reviewed articles from Medwin Publishers' open access journals.

Clear Filters

Showing 1–2 of 2 articles

"Gkioka AI" ×
HIJ Research Article Mar 5, 2026
Outcomes of Lenalidomide Relapsed/Refractory Patients
Gkioka AI, Gkiokas A, Oikonomou G, Koudouna A, Bartzi V, Nikolaou E, Panayiotidis P and Kyrtsonis MC*

Lenalidomide constitutes a key component of therapeutic strategies for multiple myeloma (MM), both in combination with dexamethasone and as maintenance treatment. However, patient…

Multiple Myeloma Lenalidomide Refractoriness iMiDs
Full Text PDF Read Article
HIJ Research Article Nov 2, 2017
Long-lasting Responses to Immunomodulatory Drugs (IMIDs) in Combination with Dexamethasone in Multiple Myeloma; Identification of Exceptional Responders at any Treatment Line
Gkioka AI, Nikolaou E, Bartzis V, Papaioannou P, Koudouna A, Kotsanti S, Petsa P, Dimou M, Maltezas D, Iliakis T, Bitsani A, Sachanas S, Sfikakis P, Panayiotis P and Kyrtsonis MC*

Background: There is a growing interest in the study of patients that achieve exceptionally long-lasting remissions although suffering from incurable neoplastic disorders. This is …

Multiple myeloma Immunomodulatory drugs Thalidomide
Full Text PDF Read Article